Neurologic Parasitic Infections in Immigrants and Travelers

Kiran Thakur; Joseph Zunt

doi:10.1055/s-0031-1287651

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2011; 31(3): 231-244
DOI: 10.1055/s-0031-1287651

Neurologic Parasitic Infections in Immigrants and Travelers

Kiran Thakur¹ ^, ² ^, ³ , Joseph Zunt⁴

¹Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
²Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
³Harvard Medical School, Boston, Massachusetts
⁴Departments of Neurology, Global Health, Medicine (Infectious Diseases) and Epidemiology, University of Washington, Harborview Medical Center, Seattle, Washington

Abstract

ABSTRACT

Infectious diseases are increasingly common in modern clinical practice and the contemporary neurologist must be aware of the clinical manifestations, potential complications, and management of common travel-related infections. The authors provide an approach to patients who present with neurologic symptoms, with a history of travel to or residence in tropical and developing countries. Although many other infections are important in this demographic, they focus on three parasitic infections that neurologists may encounter: cerebral malaria, neuroschistosomiasis, and neurocysticercosis. The epidemiology, pathophysiology, clinical manifestations, diagnostic evaluation, and treatment are discussed for each infection.

KEYWORDS

Neuroinfectious diseases - neuroschistosomiasis - cerebral malaria - neurocysticercosis

Volltext

Referenzen

REFERENCES

1 Poser C, Poser J. Neurology in the developing world (book review). Brain. 2006; 129 (6) 1624-1629
2 Han M H, Zunt J R. Neurologic aspects of infections in international travelers. Neurologist. 2005; 11 (1) 30-44
3 Talisuna A O, Bloland P, D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004; 17 (1) 235-254
4 World Health Organization .World Malaria report 2010. Available at: http://www.who.int/malaria_world_malaria_report_2010/en/index.html Accessed December 14, 2010
5 Lou J, Lucas R, Grau G E. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001; 14 (4) 810-820
6 World Health Organization. Malaria. In: International Travel and Health 2003. Geneva: World Health Organization; 2003
7 National Institute of Allergy and Infectious Diseases. The Life Cycle of the Malaria Parasite. Available at: http://www.niaid.nih.gov/topics/malaria/pages/lifecycle.aspx Accessed December 14, 2010
8 Idro R, Jenkins N E, Newton C R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005; 4 (12) 827-840
9 Snow R W, Guerra C A, Noor A M, Myint H Y, Hay S I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005; 434 (7030) 214-217
10 Walker M, Kublin J G, Zunt J R. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006; 42 (1) 115-125
11 Magowan C, Wollish W, Anderson L, Leech J. Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes. J Exp Med. 1988; 168 (4) 1307-1320
12 Brown H C, Chau T T, Mai N T et al.. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000; 55 (1) 104-111
13 WHO . Severe falciparum malaria. Trans R Soc Trop Hyg. 2000; 94 (Suppl 1) 1-90
14 Newton C R, Hien T T, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry. 2000; 69 (4) 433-441
15 Han M H, Walker M, Zunt J R. Neurological infections in the returning international traveler. Continuum: Lifelong learning in neurology. 2006; 12 (2) 133-158
16 Molyneux M E, Taylor T E, Wirima J J, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989; 71 (265) 441-459
17 Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. QJM. 1996; 89 (8) 591-597
18 Crawley J, English M, Waruiru C, Mwangi I, Marsh K. Abnormal respiratory patterns in childhood cerebral malaria. Trans R Soc Trop Med Hyg. 1998; 92 (3) 305-308
19 Marsh K, English M, Crawley J, Peshu N. The pathogenesis of severe malaria in African children. Ann Trop Med Parasitol. 1996; 90 (4) 395-402
20 Olumese P E, Gbadegesin R A, Adeyemo A A, Brown B, Walker A. Neurological features of cerebral malaria in Nigerian children. Ann Trop Paediatr. 1999; 19 (4) 321-325
21 Beare N A, Taylor T E, Harding S P, Lewallen S, Molyneux M E. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg. 2006; 75 (5) 790-797
22 Maude R J, Beare N A, Abu Sayeed A et al.. The spectrum of retinopathy in adults with Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2009; 103 (7) 665-671
23 Holding P A, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999; 93 (5) 529-534
24 Patankar T F, Karnad D R, Shetty P G, Desai A P, Prasad S R. Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology. 2002; 224 (3) 811-816
25 Looareesuwan S, Wilairatana P, Krishna S et al.. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis. 1995; 21 (2) 300-309
26 Tran T H, Day N P, Nguyen H P et al.. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996; 335 (2) 76-83
27 White N J. The treatment of malaria. N Engl J Med. 1996; 335 (11) 800-806
28 Riddle M S, Jackson J L, Sanders J W, Blazes D L. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis. 2002; 34 (9) 1192-1198
29 McIntosh H M, Olliaro P. Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop (Mars). 1998; 58 (3, Suppl) 61-62
30 Eichenlaub D, Rogler G, Hoffmann H G, Weise H J. Falciparum malaria despite pyrimethamine/suifadoxine in five tourists to East Africa. Lancet. 1982; 2 (8306) 1041-1042
31 Newton C R, Crawley J, Sowumni A et al.. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child. 1997; 76 (3) 219-226
32 Di Perri G, Di Perri I G, Monteiro G B et al.. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis. 1995; 171 (5) 1317-1322
33 Ross A G, Bartley P B, Sleigh A C et al.. Schistosomiasis. N Engl J Med. 2002; 346 (16) 1212-1220
34 Pollner J H, Schwartz A, Kobrine A, Parenti D M. Cerebral schistosomiasis caused by Schistosoma haematobium: case report. Clin Infect Dis. 1994; 18 (3) 354-357
35 Betting L E, Pirani Jr C, de Souza Queiroz L, Damasceno B P, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol. 2005; 62 (6) 1008-1010
36 Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000; 77 (1) 41-51
37 Scrimgeour E M. Non-traumatic paraplegia in northern Tanzania. Br Med J (Clin Res Ed). 1981; 283 (6297) 975-978
38 Chen M G, Mott K E. Progress in the assessment of morbidity due to Schistosoma japonicum infection: a review of recent literature. Trop Dis Bull. 1989; 86 R1-R36
39 Betting L E, Pirani Jr C, de Souza Queiroz L, Damasceno B P, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol. 2005; 62 (6) 1008-1010
40 Peregrino A JP, Oliviera R P, Porto C A et al.. Meningomieloradiculite por Schistosoma mansoni protocolo de investigação e registro de 21 casos. Arq Neuropsiquiatr. 2002; 46 49-60
41 Pittella J E. The relation between involvement of the central nervous system in Schistosomiasis mansoni and the clinical forms of the parasitosis. A review. J Trop Med Hyg. 1991; 94 (1) 15-21
42 Scrimgeour E M, Gajdusek D C. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain. 1985; 108 (Pt 4) 1023-1038
43 Nascimento-Carvalho C M, Moreno-Carvalho O A. Neuroschistosomiasis due to Schistosoma mansoni: a review of pathogenesis, clinical syndromes and diagnostic approaches. Rev Inst Med Trop Sao Paulo. 2005; 47 (4) 179-184
44 Ropper A H, Samuels M A. Adams and Victor's Principles of Neurology. 9th ed. New York, NY: McGraw-Hill Professional; 2005
45 Shu K, Zhang S, Han L, Lei T. Surgical treatment of cerebellar schistosomiasis. Neurosurgery. 2009; 64 (5) 941-943 discussion 943-944
46 Pittella J E, Lana-Peixoto M A. Brain involvement in hepatosplenic Schistosomiasis mansoni . Brain. 1981; 104 (3) 621-632
47 Carod Artal F J, Vargas A P, Horan T A, Marinho P B, Coelho Costa P H. Schistosoma mansoni myelopathy: clinical and pathologic findings. Neurology. 2004; 63 (2) 388-391
48 Gellido C L, Onesti S, Llena J, Suarez M. Spinal schistosomiasis. Neurology. 2000; 54 (2) 527
49 Selwa L M, Brunberg J A, Mandell S H, Garofalo E A. Spinal cord schistosomiasis: a pediatric case mimicking intrinsic cord neoplasm. Neurology. 1991; 41 (5) 755-757
50 Shu K, Zhang S, Han L, Lei T. Surgical treatment of cerebellar schistosomiasis. Neurosurgery. 2009; 64 (5) 941-943 discussion 943-944
51 Betting L E, Pirani Jr C, de Souza Queiroz L, Damasceno B P, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol. 2005; 62 (6) 1008-1010
52 da Rocha A J, Maia Jr A C, Ferreira N P, do Amaral L L. Granulomatous diseases of the central nervous system. Top Magn Reson Imaging. 2005; 16 (2) 155-187
53 Liu H C, Lim C C, Feng X et al.. MRI in cerebral schistosomiasis: characteristic nodular enhancement in 33 patients. AJR Am J Roentgenol. 2008; 191 (2) 582-588
54 Bill P L, Shakir R A, Newman P K, Posner C M eds.. Schistosomiasis. Tropical Neurology. Philadelphia, PA: WB Saunders Co; 1996: 295-316
55 Lighter J, Kim M, Krasinski K. Intramedullary schistosomiasis presenting in an adolescent with prolonged intermittent back pain. Pediatr Neurol. 2008; 39 (1) 44-47
56 Silva L C, Maciel P E, Ribas J G, Souza-Pereira S R, Antunes C M, Lambertucci J R. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infect Dis. 2004; 39 (11) 1618-1624
57 Ross A G, Bartley P B, Sleigh A C et al.. Schistosomiasis. N Engl J Med. 2002; 346 (16) 1212-1220
58 Fowler R, Lee C, Keystone J S. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg. 1999; 61 (1) 47-50
59 Carod Artal F J, Vargas A P, Horan T A, Marinho P B, Coelho Costa P H. Schistosoma mansoni myelopathy: clinical and pathologic findings. Neurology. 2004; 63 (2) 388-391
60 Ferrari T C. Involvement of central nervous system in the schistosomiasis. Mem Inst Oswaldo Cruz. 2004; 99 (5, Suppl 1) 59-62
61 García H H, Gonzalez A E, Evans C AW, Gilman R H. Cysticercosis Working Group in Peru . Taenia solium cysticercosis. Lancet. 2003; 362 (9383) 547-556
62 Román G, Sotelo J, Del Brutto O et al.. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ. 2000; 78 (3) 399-406
63 Senanayake N, Román G C. Epidemiology of epilepsy in developing countries. Bull World Health Organ. 1993; 71 (2) 247-258
64 Pittella J E. Neurocysticercosis. Brain Pathol. 1997; 7 (1) 681-693
65 Ong S, Talan D A, Moran G J EMERGEncy ID NET Study Group et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002; 8 (6) 608-613
66 Schantz P M, Moore A C, Muñoz J L et al.. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med. 1992; 327 (10) 692-695
67 Garg R K. Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol India. 2004; 52 (2) 171-177
68 Wallin M T, Kurtzke J F. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004; 63 (9) 1559-1564
69 Allan J C, Wilkins P P, Tsang V C, Craig P S. Immunodiagnostic tools for taeniasis. Acta Trop. 2003; 87 (1) 87-93
70 Garcia H H, Del Brutto O H. Cysticercosis Working Group in Peru . Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005; 4 (10) 653-661
71 Evans C AW. The Cysticercosis Working Group in Peru .The immunology of the host-parasite relationship in Taenia solium cysticercoids: implications for prevention and therapy. In: Garcia H H, Martinez S M, eds. Taenia Solium Taeniasis/Cysticercoids. 2nd ed. Lima: Ed Universo; 1999: 25-37
72 Garcia H H, Del Brutto O H. Cysticercosis Working Group in Peru . Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005; 4 (10) 653-661
73 Flisser A. Taeniasis and cysticercosis due to Taenia solium . Prog Clin Parasitol. 1994; 4 77-116
74 Flisser A, Correa D, Evans C AW. Taenia solium cysticercoids: new and revisited immunological aspects. In: Singh G, Prabhakar S, eds. Taenia Solium Cysticercoids: From Basic to Clinical Science. Wallingford: CABI Publishing; 2002: 15-24
75 Pittella J E. Neurocysticercosis. Brain Pathol. 1997; 7 (1) 681-693
76 Hawk M W, Shahlaie K, Kim K D, Theis J H. Neurocysticercosis: a review. Surg Neurol. 2005; 63 (2) 123-132 discussion 132
77 Del Brutto O H, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis. 1988; 10 (6) 1075-1087
78 Carpio A, Escobar A, Hauser W A. Cysticercosis and epilepsy: a critical review. Epilepsia. 1998; 39 (10) 1025-1040
79 Del Brutto O H, Santibañez R, Noboa C A, Aguirre R, Díaz E, Alarcón T A. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992; 42 (2) 389-392
80 Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol. 1996; 53 (3) 233-239
81 Couldwell W T, Zee C S, Apuzzo M L. Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery. 1991; 28 (2) 231-237
82 Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras J M, eds. Cysticercosis of the Central Nervous System. Springfield, IL: Charles C. Thomas; 1983: 27-54
83 Latovitzki N, Abrams G, Clark C, Mayeux R, Ascherl G, Sciarra D. Cerebral cysticercosis. Neurology. 1978; 28 (8) 838-842
84 Gogia S, Talukdar B, Choudhury V, Arora B S. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. 2003; 97 (4) 416-421
85 Akiguchi I, Fujiwara T, Matsuyama H, Muranaka H, Kameyama M. Intramedullary spinal cysticercosis. Neurology. 1979; 29 (11) 1531-1534
86 Garcia H H, Martinez S M. Taenia Solium Taeniasis/Cysticercoids. 2nd ed. Lima, Peru: Editorial Universo; 1999
87 Webbe G. Human cysticercosis: parasitology, pathology, clinical manifestations and available treatment. Pharmacol Ther. 1994; 64 (1) 175-200
88 Del Brutto O H, Wadia N H, Dumas M, Cruz M, Tsang V C, Schantz P M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996; 142 (1-2) 1-6
89 Wilson M, Bryan R T, Fried J A et al.. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis. 1991; 164 (5) 1007-1009
90 Garcia H H, Del Brutto O H. Cysticercosis Working Group in Peru . Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005; 4 (10) 653-661
91 Garcia H H, Del Brutto O H, Nash T E, White Jr A C, Tsang V C, Gilman R H. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg. 2005; 72 (1) 3-9
92 Schantz P M, Moore A C, Muñoz J L et al.. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med. 1992; 327 (10) 692-695
93 Chang K H, Lee J H, Han M H, Han M C. The role of contrast-enhanced MR imaging in the diagnosis of neurocysticercosis. AJNR Am J Neuroradiol. 1991; 12 (3) 509-512
94 Sheth T N, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998; 19 (1) 79-82
95 Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras J M, eds. Cysticercosis of the Nervous System. Springfield, IL: Charles C Thomas; 1983
96 Del Brutto O H, Wadia N H, Dumas M, Cruz M, Tsang V C, Schantz P M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996; 142 (1-2) 1-6
97 Takayanagui O M, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol. 1992; 49 (3) 290-294
98 Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med. 1992; 327 (10) 696-701
99 Apuzzo M L, Dobkin W R, Zee C S, Chan J C, Giannotta S L, Weiss M H. Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. J Neurosurg. 1984; 60 (2) 400-407
100 Singh G, Rajshekhar V, Murthy J M et al.. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology. 2010; 75 (24) 2236-2245

Kiran ThakurM.D.

Massachusetts General Hospital

55 Fruit Street, Boston, MA 02115

eMail: kthakur@partners.org